ALLISON TILLMAN: Open Payments
NPI 1508471459 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,279 in 87 payments from 28 companies in 2025. Trend: 2023 $1,102 · 2024 $1,467 · 2025 $2,279
Food & beverage: $2,279
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $449 |
| CeQur Corporation | 1 | $297 |
| Novo Nordisk Inc | 8 | $255 |
| SANOFI-AVENTIS U.S. LLC | 6 | $190 |
| Lilly USA, LLC | 8 | $135 |
| ABBVIE INC. | 5 | $85 |
| RECORDATI_RARE_DISEASES_INC. | 5 | $85 |
| Tandem Diabetes Care, Inc. | 8 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $68 |
| Ascendis Pharma Endocrinology Inc | 2 | $58 |
Products named: CeQur Simplicity, REPATHA, TZIELD, MOUNJARO, TEPEZZA, Wegovy, Ozempic, ISTURISA.
Industry payments across FL — which companies pay providers there.
